Characteristics | Fasting blood glucose | 2 hr-postload glucose | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
n | Pooled estimate | I2(95% CI) | Phetr | PEM | n | Pooled estimate | I2(95% CI) | Phetr | PEM | |
Overall | 11 | -0.96 (-1.52, -0.40) | 80 (65, 89) | <0.001 | Â | 8 | -2.19 (-3.19, -1.19) | 71 (40, 86) | 0.001 | Â |
Study design | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  Parallel | 5 | -0.78 (-1.93, 0.37) | 86 (69, 94) | <0.001 | 0.48 | 4 | -1.71 (-2.73, -0.70) | 59 (0, 86) | 0.07 | 0.33 |
  Crossover | 6 | -1.20 (-2.03, -0.38) | 77 (49, 90) | 0.01 |  | 4 | -3.32 (-5.90, -0.75) | 82 (54, 93) | 0.001 | |
Region | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  India | 7 | -1.43 (-2.26, -0.60) | 48 (0, 78) | 0.07 | 0.21 | 6 | -2.60 (-4.06, -1.13) | 73 (39, 88) | 0.002 | 0.50 |
  Others | 4 | -0.55 (-1.25, 0.16) | 89 (75, 95) | <0.001 |  | 2 | -1.59 (-3.08, -0.10) | 74 (0, 94) |  | |
Study precisiona | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  Below median | 5 | -0.54 (-1.15, 0.07) | 86 (69, 94) | <0.001 | 0.10 | 4 | -1.55 (-2.52, -0.57) | 67 (2, 89) | 0.03 | 0.11 |
  Above median | 6 | -1.68 (-2.62, -0.74) | 43 (0, 77) | 0.12 |  | 4 | -3.42 (-5.56, -1.28) | 67 (4, 89) | 0.03 |  |
Study populationb | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  Healthy | 2 | 0.05 (-0.51, 0.61) | 82 (23, 96) | 0.02 |  | - | - | - | - |  |
  T1DM | 1 | -4.20 (-6.73, -1.67) | - | - | 0.01 | 1 | -3.20 (-6.92, 0.52) | - | - | 0.79 |
  T2DM | 8 | -1.21 (-1.69, -0.73) | 26 (0, 67) | 0.22 |  | 7 | -2.14 (-3.19, -1.09) | 74 (45, 88) | 0.001 |  |
Randomization | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  Yes | 9 | -0.94 (-1.56, -0.32) | 83 (69, 91) | <0.001 | 0.83 | 6 | -2.54 (-3.87, -1.21) | 73 (37, 88) | 0.003 | 0.49 |
  Unknown | 2 | -1.11 (-2.10, -0.12) | 0 (0, 100) | 0.49 |  | 2 | -1.58 (-3.61, 0.45) | 81 (17, 95) | 0.02 |  |
Blinding status | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  Double-blinded | 4 | -0.44 (-1.22, 0.34) | 88 (72, 95) | <0.001 | 0.15 | 2 | -1.95 (-3.02, -0.88) | 16 (0, 55) | 0.28 | 0.74 |
  Unknown | 7 | -1.37 (-2.08, -0.67) | 47 (0, 78) | 0.08 |  | 6 | -2.43 (-3.82, -1.04) | 78 (50, 90) | 0.000 |  |
Daily dose (grams)b | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  <5 | 3 | 0.02 (-0.46, 0.50) | 63 (0, 89) | 0.07 |  | 1 | -1.34 (-2.83, 0.14) | - | - |  |
  5-10 | 4 | -1.27 (-1.80, -0.74) | 21 (0, 88) | 0.28 | 0.01 | 4 | -1.55 (-2.52, -0.57) | 67 (2, 89) | 0.04 | 0.02 |
  >10 | 4 | -2.07 (-3.58, -0.55) | 68 (9, 89) | 0.02 |  | 3 | -4.42 (-5.96, -2.89) | 8 (0, 35) | 0.58 |  |
Preparationb | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  Powdered seed | 5 | -1.12 (-1.63, -0.61) | 29 (0, 72) | 0.23 |  | 4 | -1.55 (-2.52, -0.57) | 67 (2, 89) | 0.03 |  |
  Hydro-alcoholic extract | 3 | 0.02 (-0.46, 0.50) | 63 (0, 89) | 0.07 | 0.002 | 1 | -1.34 (-2.83, 0.14) | - | - | 0.05 |
  Debitterized seed powder | 3 | -2.68 (-3.82, -1.54) | 0 (0, 90) | 0.42 |  | 3 | -4.42 (-5.96, -2.89) | 0 (0, 90) | 0.58 |  |
Study duration (days) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  <30 | 5 | -1.48 (-2.64, -0.32) | 80 (52, 91) | 0.001 | 0.39 | 3 | -4.42 (-5.96, -2.89) | 8 (0, 35) | 0.58 | 0.02 |
  > = 30 | 6 | -0.78 (-1.68, 0.11) | 83 (65, 92) | <0.001 |  | 5 | -1.49 (-2.28, -0.70) | 55 (0, 84) | 0.06 |  |
Mean Age (years) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  <43.1 | 4 | -0.73 (-1.61, 0.16) | 86 (67, 94) | <0.001 |  | 2 | -4.14 (-5.80, -2.47) | 0 (0, 100) | 0.58 |  |
  > = 43.1 | 5 | -1.11 (-1.76, -0.47) | 45 (0, 80) | 0.12 | 0.60 | 4 | -1.90 (-3.19, -0.61) | 67 (4, 89) | 0.03 | 0.21 |
Mean BMI (kg/m2) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
  <25 | 3 | -1.62 (-3.21, -0.02) | 93 (82, 97) | <0.001 | 0.29 | 2 | -2.52 (-3.75, -1.30) | 0 (0, 100) | 0.71 | 0.17 |
  > = 25 | 3 | -0.19 (-1.14, 0.76) | 74 (12, 92) | 0.02 |  | 2 | -1.01 (-1.72, -0.30) | 0 (0, 100) | 0.62 |  |